Lund University logotype, link to Lund University
This site in Swedish
Listen

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

25

May

MultiPark Debate! Aducanumab YES/NO – what is the best approach for an AD treatment?

25 May 2022 16:00 to 17:00 | Other
Poster of the debate in red and blue. Poster.

Aducanumab YES/NO – what is the best approach for an AD treatment?

A debate about Aducanumab about the best approach for an Alzheimer’s treatment. Dr. Niklas Mattsson-Carlgren and Dr. Ruben Smith will each pose their arguments in favor and against. Dr. Smith defends the “PRO” argument and Dr. Mattsson-Carlgren defends “AGAINST” Aducanumab and other anti-amyloid treatments. 

Alexa Pichet Binette and Lluís Camprubí Ferrer will moderate the debate.

  • First part: 10 minutes where each debater pose their arguments in favor and against
  • Second part: 20 minutes for rebuttal where you get to exchange opinions
  • Third part: 20 minutes interaction with the audience

Coffee will be served. 

The event is organized by the Young Multiparkers Group. Sign up here.

About the event

Location:

Segerfalk lecture hall, BMC, A10

Contact:

lluis [dot] camprubi_ferrer [at] med [dot] lu [dot] se